SIRI as a biomarker for bladder neoplasm: Utilizing decision curve analysis to evaluate clinical net benefitPierluigi Russo, Bernardo Rocco, Nazario Foschi et al.|Urologic Oncology Seminars and Original Investigations|2025Cited by 31